HK Stock Market Move | VINCENT MED (01612) surged by over 27% after profitability increased. The rise in sales orders helped drive up revenue, with mid-term net profit expected to increase by over 50% year-on-year.

date
25/07/2025
avatar
GMT Eight
Evergrande Health Industry Group (01612) surged over 27% after announcing its profits, and as of the time of writing, it had risen by 24.24%, closing at HKD 0.82 with a trading volume of HKD 4.73 million.
VINCENT MED rose more than 27% after closing, reaching 24.24% as of the report, at HK$0.82, with a trading volume of HK$47.301 million. On the news front, VINCENT MED announced that for the six months ending June 30, 2025, the group expects to record an unaudited comprehensive profit attributable to owners of the company of not less than HK$50 million, representing an increase of more than 50.0% year-on-year. The announcement stated that the Board of Directors believes that the increase is mainly attributable to the increase in sales orders of the imaging disposable products division driving the group's revenue growth, as well as the scale economy benefits and improved operating efficiency leading to an improvement in gross profit margin.